Observational vignette study to examine patient and healthcare provider perceived impact of asthma-related exacerbations in the US

  • Phaedra T. Johnson Health Economics and Outcomes Research, Optum, 11000 Optum Circle, Eden Prairie, MN 55344, United States.
  • Christopher F. Bell US Value, Evidence, and Outcomes, GlaxoSmithKline, 5 Moore Drive, Reesearch Triangle Park, NC 27709-3398, United States.
  • John White Health Economics and Outcomes Research, Optum, 11000 Optum Circle, Eden Prairie, MN 55344, United States.
  • Breanna Essoi Health Economics and Outcomes Research, Optum, 11000 Optum Circle, Eden Prairie, MN 55344, United States.
  • Linda Nelsen Value, Evidence, and Outcomes, GlaxoSmithKline, 1250 S Collegeville Road, Collegeville, PA 19426, United States.
  • Carlyne M. Averell | carlyne.m.averell@gsk.com US Value, Evidence, and Outcomes, GlaxoSmithKline, 5 Moore Drive, Reesearch Triangle Park, NC 27709-3398, United States.

Abstract

Background: Little is known about how patients and healthcare providers (HCPs) perceive the impact of asthmarelated exacerbations. This study examined the impact of asthma-related exacerbations on patients’ lives from these different perspectives. Methods: Web-based surveys were administered to a US sample of adult patients with asthma, and HCPs. Participants reviewed six vignettes describing two hypothetical patients with asthma (25-year-old/single/unemployed/ no dependents; and 45-year-old/married/employed/two young children) experiencing mild, moderate, or severe exacerbations and rated the impact on eight measures: EuroQoL-5 Dimensions (mobility, self-care, usual activities, pain/ discomfort, and anxiety/depression), sleep, household costs, and medical costs. The proportions reporting impact for each measure were calculated for each vignette; and patient responses were compared with HCP responses. Results: 302 patients with asthma and 300 HCPs completed the survey. As exacerbation severity increased, a higher proportion of patients and HCPs reported impact of exacerbations on patients with asthma. Compared with HCPs, a greater proportion of patients reported problems with pain/discomfort related to mild and moderate exacerbations. Compared with patients, HCPs were more likely to indicate sleep impact, mobility problems, and financial burden across all exacerbation severity levels; self-care problems with moderate and severe exacerbations; and problems with usual activities and anxiety/depression for severe exacerbations. Conclusions: Understanding the distinctions between how patients and HCPs perceive the impact of exacerbations is important for optimizing patient care. HCPs may be less aware of patient’s concerns about exacerbation-related pain/ discomfort. Studies are needed to further understand patient-HCP interactions regarding asthma-related exacerbations.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2019-10-21
Info
Issue
Section
Original Research Articles
Keywords:
Asthma, Exacerbations, Burden, Vignette, Patient, Healthcare provider
Statistics
  • Abstract views: 532

  • PDF: 78
  • HTML: 14
How to Cite
Johnson, P. T., Bell, C. F., White, J., Essoi, B., Nelsen, L., & Averell, C. M. (2019). Observational vignette study to examine patient and healthcare provider perceived impact of asthma-related exacerbations in the US. Multidisciplinary Respiratory Medicine, 14(1). https://doi.org/10.4081/mrm.2019.53